NONALCOHOLIC STEATOHEPATITIS (NASH)

Clinical trials for NONALCOHOLIC STEATOHEPATITIS (NASH) explained in plain language.

Never miss a new study

Get alerted when new NONALCOHOLIC STEATOHEPATITIS (NASH) trials appear

Sign up with your email to follow new studies for NONALCOHOLIC STEATOHEPATITIS (NASH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1 Terminated 1

Early trial halted for experimental fatty liver drug

Disease control Terminated

This early-stage study aimed to test the safety and initial effectiveness of an investigational drug called FT-4101 for people with NASH, a serious type of fatty liver disease, who are also overweight or obese. It involved a small group of 14 participants and was designed to see …

Matched conditions: NONALCOHOLIC STEATOHEPATITIS (NASH)

Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

NONALCOHOLIC STEATOHEPATITIS (NASH)

Get alerted when new NONALCOHOLIC STEATOHEPATITIS (NASH) trials appear

Early trial halted for experimental fatty liver drug